NYSE : STE
STERIS plc — Key statistics
Healthcare · Medical Devices · United States
Last price 227.12 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 22.14B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 22.71B |
| Enterprise Value | 24.27B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | Nov 17, 2026 |
Shares
| Measure | Value |
|---|
| Current Share Class | 97.50M |
| Shares Outstanding | 97.50M |
| Shares Change (YoY) | -0.48% |
| Shares Change (QoQ) | -0.51% |
| Owned by Insiders (%) | 0.33% |
| Owned by Institutions (%) | 100.45% |
| Float | 97.08M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 28.47 |
| Forward PE | 20.34 |
| PS Ratio | 3.76 |
| Forward PS | 3.50 |
| PB Ratio | 3.07 |
| P/TBV Ratio | 15.62 |
| P/FCF Ratio | 24.53 |
| P/OCF Ratio | 17.62 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 30.15 |
| EV / Sales | 4.02 |
| EV / EBITDA | 14.79 |
| EV / EBIT | 21.11 |
| EV / FCF | 26.22 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.91 |
| Quick Ratio | 1.17 |
| Debt / Equity | 0.28 |
| Debt / EBITDA | 1.19 |
| Debt / FCF | 2.21 |
| Interest Coverage | 18.97 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 11.39% |
| Return on Assets (ROA) | 6.80% |
| Return on Invested Capital (ROIC) | 9.68% |
| Return on Capital Employed (ROCE) | 12.16% |
| Weighted Average Cost of Capital (WACC) | 8.40% |
| Revenue Per Employee | $336,595 |
| Profits Per Employee | $44,879 |
| Employee Count | 17,937 |
| Asset Turnover | 0.57 |
| Inventory Turnover | 4.96 |
Taxes
| Measure | Value |
|---|
| Income Tax | 280.80M |
| Effective Tax Rate | 25.79% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.86 |
| 52-Week Price Change | -1.12% |
| 50-Day Moving Average | 219.74 |
| 200-Day Moving Average | 224.55 |
| Relative Strength Index (RSI) | 63.22 |
| Average Volume (20 Days) | 683,172 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 2.40M |
| Short Previous Month | 2.79M |
| Short % of Shares Out | 2.46% |
| Short % of Float | 2.47% |
| Short Ratio (days to cover) | 3.50 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 6.04B |
| Gross Profit | 2.68B |
| Operating Income | 1.15B |
| Pretax Income | 1.09B |
| Net Income | 805.00M |
| EBITDA | 1.64B |
| EBIT | 1.15B |
| Earnings Per Share (EPS) | $8.18 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 482.30M |
| Total Debt | 2.04B |
| Net Cash | -1.56B |
| Net Cash Per Share | -$16.02 |
| Equity (Book Value) | 7.22B |
| Book Value Per Share | 73.91 |
| Working Capital | 1.16B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 1.29B |
| Capital Expenditures | -362.90M |
| Depreciation & Amortization | 491.00M |
| Net Borrowing | -4.30M |
| Free Cash Flow | 925.60M |
| FCF Per Share | $9.49 |
Margins
| Measure | Value |
|---|
| Gross Margin | 44.42% |
| Operating Margin | 19.04% |
| Pretax Margin | 18.04% |
| Profit Margin | 13.33% |
| EBITDA Margin | 27.17% |
| EBIT Margin | 19.04% |
| FCF Margin | 15.33% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | $2.76 |
| Dividend Yield | 1.19% |
| Dividend Growth (YoY) | 10.00% |
| Years of Dividend Growth | 15 |
| Payout Ratio | 33.74% |
| FCF Payout Ratio | 29.07% |
| Buyback Yield | 0.48% |
| Shareholder Yield | 1.66% |
| Earnings Yield | 3.51% |
| FCF Yield | 4.08% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $260.71 |
| Price Target Difference | 11.93% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | 6.95% |
| EPS Growth Forecast (3Y) | 10.07% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Aug 25, 1998 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 5.44 |
| Piotroski F-Score | 7 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |